Sunitinib Malate Capsules 12.5 mg
Sunixar 12.5 Capsule
Sunixar 12.5 Capsule is prescribed for the treatment of Gastrointestinal stromal tumour (GIST), Metastatic renal cell carcinoma (MRCC) and Pancreatic neuroendocrine tumours (pNET).
Sunixar 12.5 Capsule Composition :-
Sunixar 12.5 Capsule consists of : Sunitinib Malate 12.5 mg
Sunitinib Malate is a tyrosine kinase inhibitor.
Sunixar 12.5 Capsule Uses :-
Sunixar 12.5 Capsule is an anti-cancer medicine. Sunixar 12.5 Capsule is used for the treatment of :
• Gastrointestinal stromal tumor (GIST):
Imatinib is useful for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumors (GISTs) in adults after treatment failure.
• Metastatic Renal Cell Carcinoma (MRCC):
Useful for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults.
• Pancreatic neuroendocrine tumor (PNET):
Useful for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (PNETs) with disease progression in adults.
Sunixar 12.5 Capsule Dosage :-
Sunixar 12.5 Capsule is a prescription medicine.
Take Sunixar 12.5 Capsule properly as your doctor tells you to take it.
Do take Sunixar 12.5 Capsule one time a day.
Do take Sunixar 12.5 Capsule with food or without food.
The recommended dosage of 50 mg once daily for GIST and MRCC for 4 consecutive weeks, followed by 2 weeks of discontinuation and a full cycle of 6 weeks throughout the duration.
The recommended dose for PNET is 37.5 mg taken once daily as prescribed.
If a dose is missed, the patient should not take an additional dose. From the next day onwards, the patient should take the usual prescribed dose.
Don't cut, crush, or chew the Sunixar 12.5 Capsule.
Sunixar 12.5 Capsule Side-effects :-
Common side effects of Sunixar 12.5 Capsule:
• Tiredness,
• Weakness,
• Diarrhea,
• Nausea,
• Loss of appetite,
• Abdominal pain,
• Taste changes
• Vomiting,
• Rash,
• Pain, swelling, or sores inside of mouth,
Sunixar 12.5 Capsule can make your skin appear pale. Your skin and hair color may become lighter. Sunixar 12.5 Capsule can also cause other skin problems such as: Dryness, cracking or thickening of the skin.
These are not all the possible side effects of Sunixar 12.5 Capsule. Consult your doctor and if you have any new or worsening side effects.
Precautions & Warnings :-
• Sunixar 12.5 Capsule can cause serious liver problems that can lead to death. Tell your doctor right away if you have signs of liver problems such as :
Yellow eyes or skin,
Dark urine,
Pain or discomfort in the right upper abdominal area.
You should have blood tests to check how your liver is working before and during treatment with Sunixar 12.5 Capsule. If you have liver problems, your doctor may temporarily stop, reduce the dose, or permanently stop treatment with Sunixar 12.5 Capsule.
• Some serious side effects of Sunixar 12.5 Capsule can occur, such as:
Heart problems.
Abnormal heart rhythm changes.
Causing irregular heartbeat.
Bleeding problems.
Having high blood pressure
Having severe stomach and intestinal problems.
Tumor lysis syndrome (TLS).
Abnormal changes in the brain.
Severe skin and mouth reactions.
Low blood sugar.
Wound healing problem.
Fetal damage.
• Before taking Sunixar 12.5 Capsule, tell your doctor about all of your medical conditions, such as:
Have a heart problem.
Have high blood pressure.
Seizures happen.
Thyroid problem.
Swelling inside the mouth Pain in the mouth, teeth, or jaw.
Have a history of low blood sugar or diabetes.
Have kidney function problems (besides cancer).
Have liver problem.
There is no bleeding problem.
Have had surgery recently or are planning to have surgery. Sunixar 12.5 Capsule should be stopped at least 3 weeks before surgery.
• Inform your doctor about all the medicines you take, some other medicine such as :
- Prescription and over-the-counter,
- Medicines,
- Vitamins,
- Herbal supplements,
Sunixar 12.5 Capsule Mfg By :-
Sun Pharmaceutical Industries Ltd
Sunixar 12.5 Capsule Price :-
MRP ₹ =
Sunixar 12.5 Capsule Storage :-
Sunixar 12.5 Capsule : store below 30°C
Classification :-
Drug Name : Sunitinib Malate,
Therapeutics Indiaction : Treatment of Gastrointestinal stromal tumour (GIST),
Metastatic renal cell carcinoma (MRCC),
Pancreatic neuroendocrine tumours (pNET).